GW Pharmaceuticals Scores EU First For Cannabinoid Drug

 
• By Andrew McConaghie

GW Pharmaceuticals is pressing on with plans to launch its epilepsy treatment Epidyolex in the EU, starting with France and Germany.

Cannabis
The first plant-derived cannabis-based drug has been approved in the EU. • Source: Shutterstock

More from Europe

More from Geography